Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting β-III-spectrin

Autor: Rebbeck, Robyn T., Andrick, Anna K., Denha, Sarah A., Svensson, Bengt, Guhathakurta, Piyali, Thomas, David D., Hays, Thomas S., Avery, Adam W.
Zdroj: In Journal of Biological Chemistry January-June 2021 296
Databáze: ScienceDirect